Tag:
Cognition Therapeutics
Latest Headlines
Latest Headlines
Cognition gets its Series A
Biotech start-up Cognition Therapeutics has rounded up $1.2 million for its Series A. Cognition hopes to develop a new therapy for Alzheimer's disease. New York-based Ogden CAP LLC led the round with
